Announcements Trials
Browse Landscape

Phase

Phase NA 68Phase 2 33Phase 3 25Phase 4 7Phase 2/3 4Phase 1 4Phase 1/2 2Phase EARLY_PHASE1 1

Status

Completed 4

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Conditions

Breast Neoplasms 91Neoplasms 75Prostatic Neoplasms 54Carcinoma, Hepatocellular 53Colorectal Neoplasms 49Leukemia, Myeloid, Acute 41Stomach Neoplasms 36Carcinoma, Non-Small-Cell Lung 36Precursor Cell Lymphoblastic Leukemia-Lymphoma 34Neoplasm Metastasis 29Pancreatic Neoplasms 27Lung Neoplasms 26Rectal Neoplasms 23Multiple Myeloma 21Hematologic Neoplasms 21Head and Neck Neoplasms 20Colonic Neoplasms 20Recurrence 19Lymphoma 19Leukemia 19Polycystic Ovary Syndrome 16Liver Neoplasms 14Esophageal Neoplasms 14Brain Neoplasms 13Myelodysplastic Syndromes 12Melanoma 12Endometrial Neoplasms 12Uterine Cervical Neoplasms 11Motor Activity 11Fatigue 11

Interventions

Olanzapine 2netupitant 1ginger extract 1Therapeutics 1Palonosetron 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2/3 × OTHER × Nausea × Clear all
NCT03040726 2023-10-17

Netupitant and Palonosetron Hydrochloride in Preventing Chronic Nausea and Vomiting in Patients With Cancer

M.D. Anderson Cancer Center

Phase 2/3 Completed
53 enrolled 15 charts

Nausea, Neoplasms, Vomiting

NCT03631004 2022-01-13

Pre-operative Olanzapine as Prophylactic Antiemetic in Oncologic Patients

Instituto do Cancer do Estado de São Paulo

Phase 2/3 Completed
100 enrolled

Nausea, Vomiting, Postoperative Nausea and Vomiting

NCT03137121 2021-08-17

Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Advanced Cancer Patients

University of Alabama at Birmingham

Phase 2/3 Completed
30 enrolled 9 charts

Nausea, Vomiting

NCT00040742 2015-11-09

Ginger in Treating Nausea in Patients Receiving Chemotherapy for Cancer

University of Rochester

Phase 2/3 Completed
745 enrolled 18 charts

Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡